4,718
Views
29
CrossRef citations to date
0
Altmetric
Research Paper/Report

Serum 25-hydroxyvitamin D levels in patients with skin diseases including psoriasis, infections, and atopic dermatitis

ORCID Icon, , , , ORCID Icon &
Article: e1442159 | Received 04 Dec 2017, Accepted 13 Feb 2018, Published online: 30 Mar 2018

References

  • Wacker M, Holick MF. Vitamin D – effects on skeletal and extraskeletal health and the need for supplementation. Nutrients. 2013;5:111–48. doi:10.3390/nu5010111. PMID:23306192.
  • Hewison M. Vitamin D and the immune system: new perspectives on an old theme. Rheum Dis Clin North Am. 2012;38:125–39. doi:10.1016/j.rdc.2012.03.012. PMID:22525848.
  • Wadhwa B, Relhan V, Goel K, Kochhar AM, Garg VK. Vitamin D and skin diseases: A review. Indian J Dermatol Venereol Leprol. 2015;81:344–55. doi:10.4103/0378-6323.159928. PMID:26144849.
  • Holick MF. Sunlight, ultraviolet radiation, vitamin D and skin cancer: how much sunlight do we need? Adv Exp Med Biol. 2014;810:1–16. PMID:25207357.
  • Jarrett P, Scragg R. A short history of phototherapy, vitamin D and skin disease. Photochem Photobiol Sci. 2017;16:283–90. doi:10.1039/C6PP00406G. PMID:27892584.
  • Autier P, Gandini S. Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. Arch Intern Med. 2007;167:1730–7. doi:10.1001/archinte.167.16.1730. PMID:17846391.
  • Durazo-Arvizu RA, Dawson-Hughes B, Kramer H, Cao G, Merkel J, Coates PM, Sempos CT. The Reverse J-Shaped Association Between Serum Total 25-Hydroxyvitamin D Concentration and All-Cause Mortality: The Impact of Assay Standardization. Am J Epidemiol. 2017;15:1–7.
  • Gelfand JM, Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB. Risk of myocardial infarction in patients with psoriasis. JAMA. 2006;296:1735–41. doi:10.1001/jama.296.14.1735. PMID:17032986.
  • Springate DA, Parisi R, Kontopantelis E, Reeves D, Griffiths CE, Ashcroft DM. Incidence, prevalence and mortality of patients with psoriasis: a U.K. population-based cohort study. Br J Dermatol. 2017;176:650–8. doi:10.1111/bjd.15021. PMID:27579733.
  • Finamor DC, Sinigaglia-Coimbra R, Neves LC, Gutierrez M, Silva JJ, Torres LD, Surano F, Neto DJ, Novo NF, Juliano Y, Lopes AC, Coimbra CG. A pilot study assessing the effect of prolonged administration of high daily doses of vitamin D on the clinical course of vitiligo and psoriasis. Dermatoendocrinol. 2013;5:222–34. doi:10.4161/derm.24808. PMID:24494059.
  • Futamura M, Leshem YA, Thomas KS, Nankervis H, Williams HC, Simpson EL. A systematic review of Investigator Global Assessment (IGA) in atopic dermatitis (AD) trials: Many options, no standards. J Am Acad Dermatol. 2016;74:288–94. doi:10.1016/j.jaad.2015.09.062. PMID:26685719.
  • Robinson A, Kardos M, Kimball AB. Physician Global Assessment (PGA) and Psoriasis Area and Severity Index (PASI): why do both? A systematic analysis of randomized controlled trials of biologic agents for moderate to severe plaque psoriasis. J Am Acad Dermatol. 2012;66:369–75. doi:10.1016/j.jaad.2011.01.022. PMID:22041254.
  • Finlay AY, Coles EC. The effect of severe psoriasis on the quality of life of 369 patients. Br J Dermatol. 1995;132:236–44. doi:10.1111/j.1365-2133.1995.tb05019.x. PMID:7888360.
  • Aleksandra Tokarz, Beata Kuśnierz-Cabała, Marek Kuźniewski, Jacek Gacoń, Małgorzata Mazur-Laskowska, Ewa ŁStępień. Seasonal effect of vitamin D deficiency in patients with acute myocardial infarction Kardiologia Polska. 2016;8:786–92.
  • Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357:266–81. doi:10.1056/NEJMra070553. PMID:17634462.
  • Gröber U, Spitz J, Reichrath J, Kisters K, Holick MF. Vitamin D: Update. 2013: From rickets prophylaxis to general preventive healthcare. Dermatoendocrinol. 2013;5:331–47. doi:10.4161/derm.26738. PMID:24516687.
  • Autier P, Boniol M, Pizot C, Mullie P. Vitamin D status and ill health: a systematic review. Lancet Diabetes Endocrinol. 2014;2:76–89. doi:10.1016/S2213-8587(13)70165-7. PMID:24622671.
  • Mokry LE, Ross S, Ahmad OS, Forgetta V, Smith GD, Goltzman D, Leong A, Greenwood CM, Thanassoulis G, Richards JB. Vitamin D and Risk of Multiple Sclerosis: A Mendelian Randomization Study. PLoS Med. 2015;12:e1001866. doi: Erratum in: PLoS Med. 2016;13:e1001981. doi:10.1371/journal.pmed.1001866. PMID:26305103.
  • Baeke F, Takiishi T, Korf H, Gysemans C, Mathieu C. Vitamin D: modulator of the immune system. Curr Opin Pharmacol. 2010;10:482–96. doi:10.1016/j.coph.2010.04.001. PMID:20427238.
  • Quirk SK, Rainwater E, Shure AK, Agrawal DK. Vitamin D in atopic dermatitis, chronic urticaria and allergic contact dermatitis. Expert Rev Clin Immunol. 2016;12:839–47. doi:10.1586/1744666X.2016.1171143. PMID:27014952.
  • Liu PT, Stenger S, Li H, Wenzel L, Tan BH, Krutzik SR, Ochoa MT, Schauber J, Wu K, Meinken C, et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science. 2006;311:1770–3. doi:10.1126/science.1123933. PMID:16497887.
  • Muehleisen B, Gallo RL. Vitamin D in allergic disease: shedding light on a complex problem. J Allergy Clin Immunol. 2013;131:324–9. doi:10.1016/j.jaci.2012.12.1562. PMID:23374263.
  • Slominski AT, Li W, Kim TK, Semak I, Wang J, Zjawiony JK, Tuckey RC. Novel activities of CYP11A1 and their potential physiological significance. J Steroid Biochem Mol Biol. 2015;151:25–37. doi:10.1016/j.jsbmb.2014.11.010. PMID:25448732.
  • Veugelers PJ, Pham TM, Ekwaru JP. Optimal Vitamin D Supplementation Doses that Minimize the Risk for Both Low and High Serum 25-Hydroxyvitamin D Concentrations in the General Population. Nutrients. 2015;7:189–208. doi:10.3390/nu7125527.
  • Lugg ST, Howells PA, Thickett DR. Optimal Vitamin D Supplementation Levels for Cardiovascular Disease Protection. Dis Markers. 2015;2015:864370. doi:10.1155/2015/864370. doi:10.1155/2015/864370. PMID:26435569.
  • Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM, Endocrine Society. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96:1911–30. doi:10.1210/jc.2011-0385. PMID:21646368.
  • Wang TJ, Zhang F, Richards JB, Kestenbaum B, van Meurs JB, Berry D, Kiel DP, Streeten EA, Ohlsson C, Koller DL, et al. Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet. 2010;376:180–8. doi:10.1016/S0140-6736(10)60588-0. PMID:20541252.
  • Holick MF, Reichrath J. Clinical utility of 1, 25-dihydroxy vitamin D3 and its analogs for the treatment of psoriasis. In: Holick MF, editor. Vitamin D. Physiology, Molecular Biologic and Clinical Aspects. Totowa, New York: The Humana Press Inc; 1999. p. 357–73.
  • MacLaughlin JA, Gange W, Taylor D, Smith E, Holick MF. Cultured psoriatic fibroblasts from involved and uninvolved sites have a partial but not absolute resistance to the proliferation-inhibition activity of 1,25-dihydroxyvitamin D3. Proc Natl Acad Sci U S A. 1985;82:5409–12. doi:10.1073/pnas.82.16.5409. PMID:2991921.
  • Gisondi P, Rossini M, Di Cesare A, Idolazzi L, Farina S, Beltrami G, Peris K, Girolomoni G. Vitamin D status in patients with chronic plaque psoriasis. Br J Dermatol. 2012;166:505–10. doi:10.1111/j.1365-2133.2011.10699.x. PMID:22013980.
  • Kamangar F, Koo J, Heller M, Lee E, Bhutani T. Oral vitamin D, still a viable treatment option for psoriasis. J Dermatolog Treat. 2013;24:261–7. doi:10.3109/09546634.2011.643219. PMID:22103655.
  • Takeshita J, Grewal S, Langan SM, Mehta NN, Ogdie A, Van Voorhees AS, Gelfand JM. Psoriasis and comorbid diseases: Epidemiology. J Am Acad Dermatol. 2017;76:377–90. doi:10.1016/j.jaad.2016.07.064. PMID:28212759.
  • Orgaz-Molina J, Buendía-Eisman A, Arrabal-Polo MA, Ruiz JC, Arias-Santiago S. Deficiency of serum concentration of 25-hydroxyvitamin D in psoriatic patients: a case-control study. J Am Acad Dermatol. 2012;67:931–8. doi:10.1016/j.jaad.2012.01.040. PMID:22387034.
  • Ogdie A, Harter L, Shin D, Baker J, Takeshita J, Choi HK, Love TJ, Gelfand JM. The risk of fracture among patients with psoriatic arthritis and psoriasis: a population-based study. Ann Rheum Dis. 2017;76:882–5. doi:10.1136/annrheumdis-2016-210441. PMID:28093419.
  • Springate DA, Parisi R, Kontopantelis E, Reeves D, Griffiths CE, Ashcroft DM. Incidence, prevalence and mortality of patients with psoriasis: a U.K. population-based cohort study. Br J Dermatol. 2017;176:650–8. doi:10.1111/bjd.15021. PMID:27579733.
  • Arakawa A, Siewert K, Stöhr J, Besgen P, Kim SM, Rühl G, Nickel J, Vollmer S, Thomas P, Krebs S, et al. Melanocyte antigen triggers autoimmunity in human psoriasis. J Exp Med. 2015;212:2203–12. doi:10.1084/jem.20151093. PMID:26621454.
  • Yang CY, Leung PS, Adamopoulos IE, Gershwin ME. The implication of vitamin D and autoimmunity: a comprehensive review. Clin Rev Allergy Immunol. 2013;45:217–26. doi:10.1007/s12016-013-8361-3. PMID:23359064.
  • Tiosano D, Hadad S, Chen Z, Nemirovsky A, Gepstein V, Militianu D, Weisman Y, Abrams SA. Calcium absorption, kinetics, bone density, and bone structure in patients with hereditary vitamin D-resistant rickets. J Clin Endocrinol Metab. 2011;96:3701–9. doi:10.1210/jc.2011-1432. PMID:21917877.
  • Perez A, Raab R, Chen TC, Turner A, Holick MF. Safety and efficacy of oral calcitriol (1,25-dihydroxyvitamin D3) for the treatment of psoriasis. Br J Dermatol. 1996;134:1070–8. doi:10.1111/j.1365-2133.1996.tb07945.x. PMID:8763427.
  • Morimoto S, Yoshikawa K, Kozuka T, Kitano Y, Imanaka S, Fukuo K, Koh E, Kumahara Y. An open study of vitamin D3 treatment in psoriasis vulgaris. Br J Dermatol. 1986;115:421–9. doi:10.1111/j.1365-2133.1986.tb06236.x. PMID:3022784.
  • Smith EL, Pincus SH, Donovan L, Holick MF. A novel approach for the evaluation and treatment of psoriasis. Oral or topical use of 1,25-dihydroxyvitamin D3 can be a safe and effective therapy for psoriasis. J Am Acad Dermatol. 1988;19:516–28. doi:10.1016/S0190-9622(88)70207-8. PMID:2459166.
  • Weinhold A, Obeid R, Vogt T, Reichrath J. Prospective Investigation of 25(OH)D3 Serum Concentration Following UVB Narrow Band Phototherapy in Patients with Psoriasis and Atopic Dermatitis. Anticancer Res. 2016;36:1439–44. PMID:26977048.
  • McCullough PJ, Lehrer D. Vitamin D: Forgotten but very safe and effective treatment for psoriasis. Orlando, FL: Poster. 20th Workshop on Vitamin D; March 28–31, 2017.
  • Wallis RS. Infectious complications of tumor necrosis factor blockade. Curr Opin Infect Dis. 2009;22:403–9. doi:10.1097/QCO.0b013e32832dda55. PMID:19491672.
  • López-Ferrer A, Vilarrasa E, Puig L. Secukinumab (AIN457) for the treatment of psoriasis. Expert Rev Clin Immunol. 2015;11:1177–88. doi:10.1586/1744666X.2015.1095092. PMID:26428036.
  • Zittermann A, Pilz S, Hoffmann H, März W. Vitamin D and airway infections: a European perspective. Eur J Med Res. 2016;21:14. doi:10.1186/s40001-016-0208-y. PMID:27009076.
  • Schauber J, Gallo RL. The vitamin D pathway: a new target for control of the skin's immune response? Exp Dermatol. 2008;17:633–9. doi:10.1111/j.1600-0625.2008.00768.x. PMID:18573153.
  • Harris VR, Cooper AJ. Atopic dermatitis: the new frontier. Med J Aust. 2017;207:351–6. doi:10.5694/mja17.00463. PMID:29020907.
  • Ong PY, Leung DY. Bacterial and Viral Infections in Atopic Dermatitis: a comprehensive review. Clin Rev Allergy Immunol. 2016;51:329–37. doi:10.1007/s12016-016-8548-5. PMID:27377298.
  • Sharief S, Jariwala S, Kumar J, Muntner P, Melamed ML. Vitamin D levels and food and environmental allergies in the United States: results from the National Health and Nutrition Examination Survey. 2005–2006. J Allergy Clin Immunol. 2011;127:1195–202. doi:10.1016/j.jaci.2011.01.017. PMID:21329969.
  • Vimaleswaran KS, Berry DJ, Lu C, Tikkanen E, Pilz S, Hiraki LT, Cooper JD, Dastani Z, Li R, Houston DK, et al. Causal relationship between obesity and vitamin D status: bi-directional Mendelian randomization analysis of multiple cohorts. PLoS Med. 2013;10:e1001383. doi:10.1371/journal.pmed.1001383. PMID:23393431.
  • Oren E, Bamerji A, Camargo CA. Vitamin D and atopic disorders in an obese population screened for vitamin D deficiency. J Allergy Clin Immunol. 2008;121:533–4. doi:10.1016/j.jaci.2007.11.005. PMID:18177693.
  • Hata TR, Audish D, Kotol P, Coda A, Kabigting F, Miller J, Alexandrescu D, Boguniewicz M, Taylor P, Aertker L, et al. A randomized controlled double-blind investigation of the effects of vitamin D dietary supplementation in subjects with atopic dermatitis. J Eur Acad Dermatol Venereol. 2014;28:781–9. doi:10.1111/jdv.12176. PMID:23638978.
  • Samochocki Z, Bogaczewicz J, Jeziorkowska R, Sysa-Jędrzejowska A, Glińska O, Karczmarewicz E, McCauliffe DP, Woźniacka A. Vitamin D effects in atopic dermatitis. J Am Acad Dermatol. 2013;69:238–44. doi:10.1016/j.jaad.2013.03.014. PMID:23643343.
  • Peroni DG, Piacentini GL, Cametti E, Chinellato I, Boner AL. Correlation between serum 25-hydroxyvitamin D levels and severity of atopic dermatitis in children. Br J Dermatol. 2011;164:1078–82. doi:10.1111/j.1365-2133.2010.10147.x. PMID:21087229.
  • Udompataikul M, Huajai S, Chalermchai T, Taweechotipatr M, Kamanamool N. The Effects of Oral Vitamin D Supplement on Atopic Dermatitis: A Clinical Trial with Staphylococcus aureus Colonization Determination. J Med Assoc Thai. 2015;98(Suppl 9):S23–30. PMID:26817206.
  • Baek JH, Shin YH, Chung IH, Kim HJ, Yoo EG, Yoon JW, Jee HM, Chang YE, Han MY. The link between serum vitamin D level, sensitization to food allergens, and the severity of atopic dermatitis in infancy. J Pediatr. 2014;165:849–54. doi:10.1016/j.jpeds.2014.06.058. PMID:25108543.
  • Lee SA, Hong S, Kim HJ, Lee SH, Yum HY. Correlation between serum vitamin D level and the severity of atopic dermatitis associated with food sensitization. Allergy Asthma Immunol Res. 2013;5:207–10. doi:10.4168/aair.2013.5.4.207. PMID:23814673.
  • Osborne NJ, Ukoumunne OC, Wake M, Allen KJ. Prevalence of eczema and food allergy is associated with latitude in Australia. J Allergy Clin Immunol. 2012;129:865–7. doi:10.1016/j.jaci.2012.01.037. PMID:22305679.
  • Batcheller P. Systematic analysis: Why so few clinical trials using vitamin D3 as the intervention fail to conclude clinical outcomes favoring the benefits of vitamin D3 as non-skeletal DMT. Orlando, FL: Poster 20th Workshop on Vitamin D; March 28–31, 2017.
  • Souberbielle JC, Body JJ, Lappe JM, Plebani M, Shoenfeld Y, Wang TJ, Bischoff-Ferrari HA, Cavalier E, Ebeling PR, Fardellone P, et al. Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: Recommendations for clinical practice. Autoimmun Rev. 2010;9:709–15. doi:10.1016/j.autrev.2010.06.009. PMID:20601202.
  • Yang HK, Choi J, Kim WK, Lee SY, Park YM, Han MY, Kim HY, Hahm MI, Chae Y, Lee KJ, et al. The association between hypovitaminosis D and pediatric allergic diseases: A Korean nationwide population-based study. Allergy Asthma Proc. 2016;37:64–69. doi:10.2500/aap.2016.37.3957. PMID:27401310.
  • Kim YH, Kim KW, Kim MJ, Sol IS, Yoon SH, Ahn HS, Kim HJ, Sohn MH, Kim KE. Vitamin D levels in allergic rhinitis: a systematic review and meta-analysis. Pediatr Allergy Immunol. 2016;27:580–90. doi:10.1111/pai.12599. PMID:27188226.
  • Martineau AR, Cates CJ, Urashima M, Jensen M, Griffiths AP, Nurmatov U, Sheikh A, Griffiths CJ. Vitamin D for the management of asthma. Cochrane Database Syst Rev. 2016;9:CD011511. PMID:27595415.
  • Berraies A, Hamzaoui K, Hamzaoui A. Link between vitamin D and airway remodeling. J Asthma Allergy. 2014;7:23–30. PMID:24729717.
  • Wang J, Thingholm LB, Skiecevičienė J, Rausch P, Kummen M, Hov JR, Degenhardt F, Heinsen FA, Rühlemann MC, Szymczak S, et al. Genome-wide association analysis identifies variation in vitamin D receptor and other host factors influencing the gut microbiota. Nat Genet. 2016;48:1396–406. doi:10.1038/ng.3695. PMID:27723756.
  • For health professionals: position statement on supplementation, blood levels and sun exposure Vitamin D Council. Vitamin D Council. Jan 12, 2010. Available at http://www.vitamindcouncil.org/further-topics/for-health-professionals-position-statement-onsupplementation-blood-levels-and-sun-exposure/. Accessed 28 Apr 2013.
  • Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM. Guidelines for preventing and treating vitamin D deficiency and insufficiency revisited. J Clin Endocrinol Metab. 2012;97:1153–8. doi:10.1210/jc.2011-2601. PMID:22442274.
  • Ross AC, Taylor CL, Yaktine AL, Del Valle HB. Dietary reference intakes for calcium and vitamin D. Washington: National Academy of Sciences; 2010. p. 0-309-16394-3.
  • Płudowski P, Karczmarewicz E, Bayer M, Carter G, Chlebna-Sokół D, Czech-Kowalska J, Dębski R, Decsi T, Dobrzańska A, Franek E, et al. Practical guidelines for the supplementation of vitamin D and the treatment of deficits in Central Europe – recommended vitamin D intakes in the general population and groups at risk of vitamin D deficiency. Endokrynol Pol. 2013;64:319–27. doi:10.5603/EP.2013.0012. PMID:24002961.
  • Akan A, Azkur D, Ginis T, Toyran M, Kaya A, Vezir E, Ozcan C, Ginis Z, Kocabas CN. Vitamin D level in children is correlated with severity of atopic dermatitis but only in patients with allergic sensitizations. Pediatr Dermatol. 2013;30:359–63. doi:10.1111/pde.12058. PMID:23289912.
  • Amestejani M, Salehi BS, Vasigh M, Sobhkhiz A, Karami M, Alinia H, Kamrava SK, Shamspour N, Ghalehbaghi B, Behzadi AH. Vitamin D supplementation in the treatment of atopic dermatitis: a clinical trial study. J Drugs Dermatol. 2012;11:327–30. PMID:22395583.
  • Baïz N, Dargent-Molina P, Wark JD, Souberbielle JC, Annesi-Maesano I, EDEN Mother-Child Cohort Study Group. Cord serum 25-hydroxyvitamin D and risk of early childhood transient wheezing and atopic dermatitis. J Allergy Clin Immunol. 2014;133:147–53. doi:10.1016/j.jaci.2013.05.017. PMID:23810764.
  • Camargo CA Jr, Ganmaa D, Sidbury R, Erdenedelger Kh, Radnaakhand N, Khandsuren B. Randomized trial of vitamin D supplementation for winter-related atopic dermatitis in children. J Allergy Clin Immunol. 2014;134:831–5. doi:10.1016/j.jaci.2014.08.002. PMID:25282565.
  • Cheng HM, Kim S, Park GH, Chang SE, Bang S, Won CH, Lee MW, Choi JH, Moon KC. Low vitamin D levels are associated with atopic dermatitis, but not allergic rhinitis, asthma, or IgE sensitization, in the adult Korean population. J Allergy Clin Immunol. 2014;133:1048–55. doi:10.1016/j.jaci.2013.10.055. PMID:24388009.
  • Gilaberte Y, Sanmartín R, Aspiroz C, Hernandez-Martin A, Benito D, Sanz-Puertolas P, Alonso M, Torrelo A, Torres C. Correlation Between Serum 25-Hydroxyvitamin D and Virulence Genes of Staphylococcus aureus Isolates Colonizing Children with Atopic Dermatitis. Pediatr Dermatol. 2015;32:506–13. doi:10.1111/pde.12436. PMID:25491017.
  • Grant CC, Crane J, Mitchell EA, Sinclair J, Stewart A, Milne T, Knight J, Gilchrist C, Camargo CA Jr. Vitamin D supplementation during pregnancy and infancy reduces aeroallergen sensitization: a randomized controlled trial. Allergy. 2016;71:1325–34. doi:10.1111/all.12909. PMID:27060679.
  • Han TY, Kong TS, Kim MH, Chae JD, Lee JH, Son SJ. Vitamin D Status and Its Association with the SCORAD Score and Serum LL-37 Level in Korean Adults and Children with Atopic Dermatitis. Ann Dermatol. 2015;27:10–14. doi:10.5021/ad.2015.27.1.10. PMID:25673925.
  • Javanbakht MH, Keshavarz SA, Djalali M, Siassi F, Eshraghian MR, Firooz A, Seirafi H, Ehsani AH, Chamari M, Mirshafiey A. Randomized controlled trial using vitamins E and D supplementation in atopic dermatitis. J Dermatolog Treat. 2011;22:144–50. doi:10.3109/09546630903578566. PMID:20653487.
  • Sidbury R, Sullivan AF, Thadhani RI, Camargostr CA Jr. Randomized controlled trial of vitamin D supplementation for winter-related atopic dermatitis in Boston: A pilot study. Br J Dermatol. 2008;159:245–57. doi:10.1111/j.1365-2133.2008.08601.x. PMID:18489598.
  • Wang SS, Hon KL, Kong AP, Pong HN, Wong GW, Leung TF. Vitamin D deficiency is associated with diagnosis and severity of childhood atopic dermatitis. Pediatr Allergy Immunol. 2014;25:30–35. doi:10.1111/pai.12167. PMID:24383670.
  • Heimbeck I, Wjst M, Apfelbacher CJ. Low vitamin D serum level is inversely associated with eczema in children and adolescents in Germany. Allergy. 2013;68:906–10. doi:10.1111/all.12167. PMID:23751100.
  • Wawro N, Heinrich J, Thiering E, Kratzsch J, Schaaf B, Hoffmann B, Lehmann I, Bauer CP, Koletzko S, von Berg A, et al. Serum 25(OH)D concentrations and atopic diseases at age 10: results from the GINIplus and LISAplus birth cohort studies. BMC Pediatr. 2014;14:286. doi:10.1186/s12887-014-0286-3. PMID:25421846.
  • Berents TL, Lødrup Carlsen KC, Mowinckel P, Sandvik L, Skjerven HO, Rolfsjord LB, Kvenshagen B, Hunderi JO, Bradley M, et al. Vitamin D levels and atopic eczema in infancy and early childhood in Norway: a cohort study. Br J Dermatol. 2016;175:95–101. doi:10.1111/bjd.14537. PMID:26972308.
  • Chawes BL, Bønnelykke K, Jensen PF, Schoos AM, Heickendorff L, Bisgaard H. Cord blood 25(OH)-vitamin D deficiency and childhood asthma, allergy and eczema: the COPSAC2000 birth cohort study. PLoS One. 2014;9:e99856. doi:10.1371/journal.pone.0099856. PMID:24925304.
  • Chiu YE, Havens PL, Siegel DH, Ali O, Wang T, Holland KE, Galbraith SS, Lyon VB, Drolet BA. Serum 25-hydroxyvitamin D concentration does not correlate with atopic dermatitis severity. J Am Acad Dermatol. 2013;69:40–46. doi:10.1016/j.jaad.2013.01.010. PMID:23415685.
  • Robl R, Uber M, Abagge KT, Lima MN, Carvalho VO. Serum Vitamin D Levels Not Associated with Atopic Dermatitis Severity. Pediatr Dermatol. 2016;33:283–8. doi:10.1111/pde.12795. PMID:26862046.
  • Thuesen BH, Heede NG, Tang L. No association between vitamin D and atopy, asthma, lung function or atopic dermatitis: a prospective study in adults. Allergy. 2015;70:1501–4. doi:10.1111/all.12704. PMID:26214285.